NVRS.CN is trading at 8.7% up now at $1.37 on relatively light, news-less action. Recent movement follows a volatile stretch in late June, but there are no fresh company announcements, earnings, or major analyst actions since the June 5, 2026 corporate update about its psilocybin and regenerative medicine plans. The move appears driven by short-term trading interest rather than a clearly documented catalyst.